These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 12193850)

  • 1. Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine.
    Sueda S; Kohno H; Fukuda H; Inoue K; Suzuki J; Watanabe K; Ochi T; Uraoka T
    Coron Artery Dis; 2002 Jun; 13(4):231-6. PubMed ID: 12193850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2004 Dec; 15(8):491-7. PubMed ID: 15585990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Absence of induced spasm by intracoronary injection of 50 micrograms acetylcholine in the right coronary artery: usefulness of 80 micrograms of acetylcholine as a spasm provocation test].
    Sueda S; Mineoi K; Kondo T; Yano K; Ochi T; Ochi N; Fukuda H; Kukita H; Kawada H; Matsuda S; Uraoka T
    J Cardiol; 1998 Sep; 32(3):155-61. PubMed ID: 9783236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine.
    Sueda S; Kohno H; Fukuda H; Ochi N; Kawada H; Hayashi Y; Uraoka T
    Coron Artery Dis; 2003 Sep; 14(6):451-7. PubMed ID: 12966266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.
    Sato K; Kaikita K; Nakayama N; Horio E; Yoshimura H; Ono T; Ohba K; Tsujita K; Kojima S; Tayama S; Hokimoto S; Matsui K; Sugiyama S; Yamabe H; Ogawa H
    J Am Heart Assoc; 2013 Jul; 2(4):e000227. PubMed ID: 23858100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximal acetylcholine dose of 200 μg into the left coronary artery as a spasm provocation test: comparison with 100 μg of acetylcholine.
    Sueda S; Kohno H; Miyoshi T; Sakaue T; Sasaki Y; Habara H
    Heart Vessels; 2015 Nov; 30(6):771-8. PubMed ID: 25179297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.
    Sueda S; Fujimoto K; Sasaki Y; Sakaue T; Yoshii T; Habara H; Kohno H
    Heart Vessels; 2019 May; 34(5):745-754. PubMed ID: 30474702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.
    Sueda S; Ochi T; Yano K; Mineoi K; Kondou T; Ochi N; Hayashi Y; Kukita H; Matsuda S; Kawada H; Tsuruoka T; Uraoka T
    Jpn Circ J; 2000 Aug; 64(8):559-65. PubMed ID: 10952150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential incidence and type of spasm according to coronary arterial location.
    Sueda S; Kohno H
    Coron Artery Dis; 2016 Jun; 27(4):273-6. PubMed ID: 26901444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential spasm provocation tests might overcome a limitation of the standard spasm provocation tests.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Coron Artery Dis; 2015 Sep; 26(6):490-4. PubMed ID: 25974266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One of six patients with non-ischemic heart disease exhibit provoked coronary spasms: non-ischemic heart disease associated with ischemia?
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Intern Med; 2015; 54(3):281-6. PubMed ID: 25748736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Heart Vessels; 2016 Mar; 31(3):322-9. PubMed ID: 25539623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Usefulness of Intracoronary Acetylcholine 200 μg Into the Left Coronary Artery as Vasoreactivity Testing: Comparisons With Intracoronary Acetylcholine Maximum 100 μg.
    Sueda S; Hayashi Y; Ono H; Sakaue T; Ikeda S
    Clin Cardiol; 2024 Oct; 47(10):e70001. PubMed ID: 39355891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-related Differences in Patients with Positive Coronary Spasm as Identified by Acetylcholine Testing.
    Sueda S; Sakaue T
    Intern Med; 2021 Aug; 60(15):2357-2365. PubMed ID: 33583899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm.
    Sueda S; Kohno H; Inoue K; Fukuda H; Suzuki J; Watanabe K; Ochi N; Kawada H; Uraoka T
    Circ J; 2002 Sep; 66(9):826-30. PubMed ID: 12224820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.
    Sueda S; Miyoshi T; Sasaki Y; Sakaue T; Habara H; Kohno H
    Heart Vessels; 2016 Feb; 31(2):137-42. PubMed ID: 25366987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Induction of coronary arterial spasm by intracoronary administration of acetylcholine in patients with vasospastic angina].
    Miwa K; Fujita M; Ejiri M; Sakai O; Asanoi H; Nozawa T; Araie E; Miyagi Y; Sasayama S
    J Cardiol; 1989 Sep; 19(3):749-55. PubMed ID: 2641769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholine-Provoked Coronary Spasm at Site of Significant Organic Stenosis Predicts Poor Prognosis in Patients With Coronary Vasospastic Angina.
    Ishii M; Kaikita K; Sato K; Tanaka T; Sugamura K; Sakamoto K; Izumiya Y; Yamamoto E; Tsujita K; Yamamuro M; Kojima S; Soejima H; Hokimoto S; Matsui K; Ogawa H
    J Am Coll Cardiol; 2015 Sep; 66(10):1105-15. PubMed ID: 26337988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of omitting provocation test with 50 μg of acetylcholine in left coronary artery.
    Saito Y; Kitahara H; Shoji T; Tokimasa S; Nakayama T; Sugimoto K; Fujimoto Y; Kobayashi Y
    Heart Vessels; 2017 Jun; 32(6):685-689. PubMed ID: 27873006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and clinical characteristics according to intracoronary acetylcholine dose in patients with myocardial bridge.
    Im SI; Rha SW; Choi BG; Choi SY; Kim SW; Na JO; Choi CU; Lim HE; Kim JW; Kim EJ; Park CG; Seo HS; Oh DJ
    Cardiology; 2013; 125(4):250-7. PubMed ID: 23816809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.